International Journal of Research in Pharmacy and Allied Science

Author(s): Mohd Bilal Sufi; Vaishnavi Daldale*; Irshad Ahmed

DOI: https://doi.org/10.71431/IJRPAS.2026.5712

Views: 12 (pdf),       490 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Vaishnavi Daldale; Irshad Ahmed. To develop and validate the stability indicating method for Empagliflozin and Linagliptin using HPLC method. IJRPAS, July 2026; 5(7): 153-173.   https://doi.org/10.71431/IJRPAS.2026.5712

Author(s): Mohd Bilal Sufi; Shantanu Burange*; Rajlaxmi Deolekar

DOI: https://doi.org/10.71431/IJRPAS.2026.5711

Views: 16 (pdf),       410 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Shantanu Burange; Rajlaxmi Deolekar. To develop and validate the stability indicating method for repaglinide and voglibose using HPLC method. IJRPAS, July 2026; 5(7): 130-152.   https://doi.org/10.71431/IJRPAS.2026.5711

Author(s): Mohd Bilal Sufi; Shaikh Riyaj Khayumsab*; Rajlaxmi Deolekar

DOI: https://doi.org/10.71431/IJRPAS.2026.5717

Views: 10 (pdf),       395 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Shaikh Riyaj Khayumsab*; Rajlaxmi Deolekar. To study the effect of various superdisintegrants and binders in the Formulation and Evaluation of Labetalol Rapid Disintegrating Tablet. IJRPAS, July 2026; 5(7): 255-277.   https://doi.org/10.71431/IJRPAS.2026.5717

Author(s): Mohd Bilal Sufi; Sakshi Bobade *; Rajlaxmi Deolekar

DOI: https://doi.org/10.71431/IJRPAS.2026.5718

Views: 5 (pdf),       364 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Sakshi Bobade *; Rajlaxmi Deolekar.To Develop and Validate the Stability Indicating Method for Ezetimibe and Rosuvastatin Using HPLC Method. IJRPAS, July 2026; 5(7): 278-301.   https://doi.org/10.71431/IJRPAS.2026.5718

Author(s): Mohd Bilal Sufi; Mohd Julebib Mohd Shafique*; Rajlaxmi Deolekar

DOI: https://doi.org/10.71431/IJRPAS.2026.5704

Views: 8 (pdf),       348 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Mohd Julebib Mohd Shafique; Rajlaxmi Deolekar. To study the effect of Eudragit RL and RS in the formulation and Evaluation of Olmesartan Matrix Tablet. IJRPAS, July 2026; 5(7): 35-55.   https://doi.org/10.71431/IJRPAS.2026.5704

Author(s): Mohd Bilal Sufi; Mohammad Tabish*; Rajlaxmi Deolekara

DOI: https://doi.org/10.71431/IJRPAS.2026.5709

Views: 5 (pdf),       226 (html)

Access: Open Access

Cite: Mohd Bilal Sufi; Mohammad Tabish; Rajlaxmi Deolekara. Formulation and Evaluation of Mouth Dissolving Film of Irbesartan. IJRPAS, July 2026; 5(7): 100-116.   https://doi.org/10.71431/IJRPAS.2026.5709